CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,350,000 | +51.7% | 95,847 | +51.3% | 0.01% | +75.0% |
| Q4 2020 | $7,480,000 | +240.5% | 63,333 | +220.4% | 0.00% | +100.0% |
| Q3 2020 | $2,197,000 | +37.2% | 19,768 | +26.1% | 0.00% | +100.0% |
| Q2 2020 | $1,601,000 | -43.8% | 15,671 | -40.6% | 0.00% | -50.0% |
| Q1 2020 | $2,849,000 | -41.7% | 26,393 | -37.1% | 0.00% | -50.0% |
| Q4 2019 | $4,885,000 | -46.8% | 41,973 | -47.7% | 0.00% | -42.9% |
| Q3 2019 | $9,180,000 | +13.1% | 80,200 | -5.9% | 0.01% | +16.7% |
| Q2 2019 | $8,120,000 | +37.0% | 85,200 | +31.2% | 0.01% | 0.0% |
| Q1 2019 | $5,926,000 | +159.2% | 64,947 | +115.8% | 0.01% | +100.0% |
| Q4 2018 | $2,286,000 | -15.4% | 30,094 | -10.9% | 0.00% | 0.0% |
| Q3 2018 | $2,703,000 | +3.8% | 33,793 | +29.0% | 0.00% | +50.0% |
| Q2 2018 | $2,603,000 | +25930.0% | 26,202 | +21377.0% | 0.00% | – |
| Q1 2018 | $10,000 | -85.5% | 122 | -86.0% | 0.00% | – |
| Q4 2017 | $69,000 | – | 871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|